BEAM
Beam Therapeutics is a biotechnology company focused on developing precision genetic medicines using base editing to treat genetic diseases. The company emphasizes clinically validated delivery technologies, including electroporation, nonviral and viral modalities, to advance its base editing programs. With operations in locations such as Cambridge, Massachusetts and Durham, North Carolina, Beam aims to expand the potential of gene-based editing and bring novel therapies to patients through pipelines and clinical trials.